Inari Medical Inc.

AI Score

0

Unlock

79.47
0.17 (0.21%)
At close: Jan 15, 2025, 9:49 AM

Company Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States.

The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism.

It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.

The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.

Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Inari Medical Inc.
Inari Medical Inc. logo
Country United States
IPO Date May 22, 2020
Industry Medical - Devices
Sector Healthcare
Employees 1,300
CEO Andrew J. Hykes

Contact Details

Address:
6001 Oak Canyon
Irvine, California
United States
Website https://www.inarimedical.com

Stock Details

Ticker Symbol NARI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001531048
CUSIP Number 45332Y109
ISIN Number US45332Y1091
Employer ID 45-2902923
SIC Code 3841

Key Executives

Name Position
Andrew J. Hykes Chief Executive Officer, President & Director
Hussain Rangwala Chief Technology Officer
Kevin Strange Chief Financial Officer
Dr. Thomas M. Tu M.D. Chief Medical Officer
Eric Khairy Senior Vice President of Marketing
Karen Silva Vice President of Finance & Accounting
Neil Bhalodkar Vice President of Investor Relations
Paul A. Koehn Senior Vice President of Operations
Shannon Trevino General Counsel & Corporate Secretary
Tara Dunn Senior Vice President & GM of LimFlow

Latest SEC Filings

Date Type Title
Jan 08, 2025 4 Filing
Jan 07, 2025 SC14D9C Filing
Jan 07, 2025 SC TO-C Filing
Jan 07, 2025 SC TO-C Filing
Jan 06, 2025 SC14D9C Filing
Jan 06, 2025 8-K Current Report
Jan 03, 2025 4 Filing
Jan 03, 2025 4 Filing
Jan 03, 2025 4 Filing
Jan 03, 2025 4 Filing